Supplemental Materials and Methods Genetic Mapping For those mutants where the enhancement bred true, if the enhancement was inherited with the p[w+] chromosome, this indicated that the enhancing mutation was on the second chromosome, and male flies of the genotype w-; p[w+], * / +; Df(3R)p13/ TM6B were selected and bred to w-; Cyo / Sco virgin females. w-; p[w+], * / Cyo; +/ TM6B flies were selected based on eye color, and self crossed to create independent stocks. If the mutation was not inherited with the p[w+], this indicated that the enhancing mutation was on the third chromosome, and males of the genotype w-; +/ +; Df(3R)p13, e, */ TM6B were selected by the presence of the ebony marker, and the absence of the p[w+] marker, and used to create independent stocks. Those mutants which segregated with the X chromosome were discarded. Complementation and mapping: Chromosome 2: For mutants isolated on the second chromosome, each mutant was tested for complementation by crossing it to each other mutant on the second chromosome. Alleles were then separated into different groups based on their inability to complement one another. To rule out the presence of mutations that dominantly affect eye development directly, each second chromosome mutation was also tested individually for failure to complement a known allele of Star, mutations in which show a dominant rough eye phenotype when heterozygous. Only one Star allele was isolated in this screen out of 15 total enhancers on the second chromosome. We also isolated three separate complementation groups on the second chromosome that consisted of multiple alleles (Group A consisting of 2 lethal alleles, Group B consisting of 4 lethal alleles, and Group C consisting of 1 lethal and 1 temperature sensitive lethal allele), 1 allele of Star, and 6 additional enhancers that did not separate into any complementation group, and were also not alleles of Star. We concluded that these 6 additional mutants on the second chromosome represent single hit mutants in unidentified loci, and were not further characterized. Single lethal representative mutants from each complementation group were then crossed to the second Chromosome Bloomington Deficiency collection (http://flystocks.bio.indiana.edu/Browse/df-dp/dfkit.htm), and those deficiencies that failed to complement these mutants were further analyzed. Through this deficiency mapping, both alleles of complementation Group A failed to complement Bloomington Deficiency Df(2L)JS17 (BL#1567), which deletes the lilliputian gene (among others). Single mutations in lilliputian were obtained (lilliXS407, lilliXS575, lilliA17-2, lilliS35), and tested for complementation with each of the alleles of this complementation group, and each failed to complement both alleles (Table I). We therefore concluded that complementation Group A represented mutations in the lilliputian gene, and renamed the alleles of this group as lilliGD17, and lilliAG5. Concurrent with the second chromosome deficiency mapping, we attempted mapping each complementation group through meiotic mapping using molecularly defined P element insertions as described (ZHAI et al. 2003). This method utilizes two independent alleles within a complementation group, and maps the lethality associated with these trans-heterozygous combinations to a number of molecularly characterized P element insertions located at various intervals along the length of the second chromosome. In this fashion we mapped the lethality of two of the four alleles of complementation Group B to less than .01% from P element P{SUPor-P}KG00569 (BL#13139). P{SUPor-P}KG00569 has a cytological position of 21B1 as reported by Flybase (http://flybase.org/reports/FBti0021228.html), and 21A5 as reported by (ZHAI et al. 2003). It is reported as having a molecular map position of 66,954 (ZHAI et al. 2003). We therefore tested for complementation of the alleles of this group with deficiencies that removed genes within these cytological locations, and found that all four alleles failed to complement Df(2L)ED19 (BL#8901), which deletes the kismet gene (among others). We obtained single lethal mutations in kismet (kis1, and kisk13416) and found that all four alleles of complementation Group B failed to complement both of these alleles. We therefore concluded that complementation Group B represented mutations in the kismet gene, and renamed the alleles of this group as kisEC1, kisLM27, kisAS21, and kisAO9. Concurrent with the second chromosome deficiency and meiotic mapping, we crossed each second chromosome allele to the candidate gene daughterless, which is on the second chromosome in Drosophila, and which was previously shown to affect Atonal protein expression (BROWN et al. 1996). We found that Complementation Group C failed to complement known alleles of daughterless. Complementation Group C consists of 1 lethal and 1 temperature sensitive lethal allele. The lethal allele of this group (which we named daIB21) is fully lethal at both 25C and 29C. This allele fully fails to complement a null allele of da (daUX, 0% complementation at both 25C and 29C), and partially fails to complement a temperature sensitive allele at 25C (da1, 45% complementation), and fully fails to complement a temperature sensitive allele at 29C (da1, 0% complementation). The temperature sensitive allele of this group (which we named daAB12) is partially lethal at 25C (51% viability), and nearly fully lethal at 29C (9% viability). Trans-heterozygous daAB12/ daIB21 flies are partially viable at both 25C (27% viability) and 29C (24% viability). daAB12 partially complements a null allele of da (daUX, 81% complementation at 25C, 51% complementation at 29C). Chromosome 3: For mutants isolated on the third chromosome, each mutant was first tested for complementation to the hedgehog gene as a potential candidate, as we had established that null alleles of hedgehog were dominant enhancers of our loss-of-function atonal phenotype (Figure 2J), and the hedgehog gene is on the third chromosome. We found that of the 33 third chromosome mutations, three failed to complement the lethality associated with a hedgehog null mutant (hhAC). We therefore concluded these mutants represented mutations in the hedgehog gene, and renamed these alleles as hhFS1, hhMM2, and hhRM2. We next mapped each of the mutations on the third chromosome by looking for genetic linkage between the enhancement of our atonal loss-offunction eye phenotype, and the presence of either the Df(3R)p13 (cytological breakpoints 84F1-85B9), or ebony (cytological position 93C7-93D1), both of which are present on the mutagenized chromosome. Df(3R)p13, e, */ TM6B flies were crossed to w-; ato1090/ TM6B. Df(3R)p13, e, */ ato1090 display an enhanced atonal loss-of-function eye phenotype, and virgin females of this genotype were crossed to Df(3R)p13, e/ TM6B males. F1 genotype ato1090/ Df(3R)p13 flies were then scored for the presence or absence of the enhanced atonal phenotype in either a wild type or ebony background. We found that four mutations were strongly linked to the Df(3R)p13 deficiency, and we tested for complementation of these alleles with mutants in candidate genes close to the deficiency. We found that four enhancer mutants showed small rough eyes when transheterozygous with mutations in the roughened eye gene (roe1, and roe3). Roughened eye (roe) is a differentially expressed transcript that contains part of the rotund (rn) gene (ST PIERRE et al. 2002), and the roe mutants that we tested specifically knock out only roe function (ST PIERRE et al. 2002). We therefore tested mutations that specifically affect only rn gene function (rn19, and rn5) and found that all four alleles showed normal eyes. Additionally, all four alleles also show small rough eyes when trans-heterozygous for a mutation that removes both rn and roe function (rn16) (ST PIERRE et al. 2002). Importantly, the Df(3R)p13 chromosome shows normal eyes when trans-heterozygous with both rn specific and roe specific mutants, indicating that the rough eyes observed are associated with enhancer mutations on the Df(3R)p13 chromosome and not with the deletion within the chromosome itself. Based on these results, we concluded these mutants represented mutations in the roughened eye gene, and renamed these alleles as roeSM8, roeBM10, roeKK16, and roeKM29. For the remaining 26 alleles, each was recombined on to the ato1090 chromosome, and each was tested for complementation against each other. No further complementation groups were obtained in this fashion. Thus, we concluded that each of these mutations represents single hit mutations in undefined loci. It may be that by performing further mutatgenesis, additional alleles of these genes may be obtained.